MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters AbbVie on Tuesday said longtime executive Robert Michael will become the company’s new CEO, replacing Richard Gonzalez. Michael, who is AbbVie’s president and … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021. Brian Snyder | Reuters AbbVie on Wednesday said it will acquire neuroscience drugmaker Cerevel Therapeutics for roughly $8.7 billion. Under the terms of the deal, AbbVie will pay $45 per share for Cerevel. … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion. Shares of ImmunoGen jumped more than 80% … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters A federal judge on Friday declined to block the Biden administration from implementing Medicare drug price negotiations, upholding for now … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration, Eliquis is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images Medicare is set to negotiate prices for 10 different drugs with manufacturers in a bid to make those … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Rafael Henrique | Lightrocket | Getty Images CVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arthritis treatment Humira that will sell for 80% below the price of the brand-named drug. The move is part of the company’s new … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Merck & Co. Inc. Januvia brand medication, used to treat type2 diabetes, sit on a pharmacy shelf in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Medicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The seal of the US Chamber of Commerce is under restoration at its headquarters in Washington, DC Andrew Harrer | Bloomberg | Getty Images The U.S. Chamber of Commerce asked a federal judge in Ohio on Wednesday to block Medicare’s new powers to negotiate drug prices … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Hepatitis C virus BSIP | UIG | Getty Images The vast majority of people in the U.S. who test positive for hepatitis C have not been cured because of the high cost of oral antiviral treatments and barriers posed by insurance plans, federal health officials said … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pharmaceutical CEOs testify before the Senate Finance Committee on “Drug Prices in America: A Prescription for Change, Part II” on February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, Chairman and CEO of AbbVie Inc; Pascal Soriot, CEO and Managing Director … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE (L-R) Richard A. Gonzalez, Chairman and CEO of AbbVie Inc., Pascal Soriot, CEO and CEO of AstraZeneca, Giovanni Caforio, Chairman and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President and worldwide chairman of Janssen Pharmaceuticals, Johnson & Johnson, Kenneth C. Frazier, chairman and CEO … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Department of Health and Human Services plans to release a list of 10 Medicare-covered drugs for price negotiations in September, the first stage in a long-awaited push to lower costs for the elderly. Speaking to reporters Wednesday, HHS officials outlined the federal government’s plan to … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We never like to sell on a bad day. But after a dubious quarter, we decided to exit. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the New York Stock Exchange (NYSE) on October 27, 2022 in New York City. Stocks continued to rally on Thursday, with the Dow up nearly 400 points after a new GDP report beat expectations. Spencer Platt | Getty Images . MY NUMBER 1 … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It was a solid quarter for Johnson & Johnson, but the strong dollar is and will remain a headwind for the foreseeable future. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Investment Club holds its “morning meeting” every weekday at 10:20 a.m. ET. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 2-Year Treasury Remains the Right Buy When to Buy Our Tokens Quick Mentions: TJX, DIS, ABBV 1. 2-Year Treasury Remains the … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Let’s Let Our Stocks Run on Fed Day Firms with strong pricing are the winners here. Quick Mentions: CSCO, NVDA, QCOM, … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist collects drugs for prescriptions at the pharmacy. Simon Dawson | Bloomberg | Getty Images Medicare is poised to renegotiate the prices of some of its most expensive drugs in a historic expansion of its power that could cut costs for many seniors as well … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE AbbVie hasn’t had quite the quarter, but Friday’s selloff is a bit puzzling. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the New York Stock Exchange (NYSE) on January 18, 2022 in New York City. The Dow Jones Industrial Average fell nearly 500 points in morning trading as investors weighed quarterly earnings and other economic news in a shortened trading week. Spencer Platt | … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We are collecting money that is about the same as the one we put to work last Friday in three deals when the market was much lower. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We are now seeing a pretty good level in the whole market to start raising some money. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We will make more profit in AbbVie on Monday morning after the stock has achieved impressive growth recently. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Despite some flawed results here and there, we saw strength in all the right places in AbbVie’s fourth-quarter earnings report. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE While we wait for the market to appreciate Abbvie more, a dividend of about 4.15% pays off nicely for our patience. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source